According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “
Other research analysts have also recently issued research reports about the company. Jefferies Group LLC set a $63.00 price target on U.S. Physical Therapy and gave the stock a hold rating in a research report on Saturday, March 18th. Barrington Research cut U.S. Physical Therapy from an outperform rating to a market perform rating in a research report on Friday, March 17th.
U.S. Physical Therapy (NYSE:USPH) opened at 64.00 on Tuesday. U.S. Physical Therapy has a 52 week low of $48.71 and a 52 week high of $78.00. The stock has a market cap of $801.34 million, a P/E ratio of 33.16 and a beta of 0.91. The stock has a 50 day moving average of $67.05 and a 200-day moving average of $66.87.
TRADEMARK VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/04/21/u-s-physical-therapy-inc-usph-lifted-to-hold-at-zacks-investment-research-updated.html.
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 5th. Shareholders of record on Monday, April 17th will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date is Wednesday, April 12th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.17. U.S. Physical Therapy’s payout ratio is currently 35.05%.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BlackRock Fund Advisors boosted its stake in U.S. Physical Therapy by 6.3% in the third quarter. BlackRock Fund Advisors now owns 927,868 shares of the company’s stock valued at $58,177,000 after buying an additional 54,747 shares during the period. Summit Global Investments purchased a new stake in U.S. Physical Therapy during the fourth quarter valued at $484,000. Schroder Investment Management Group boosted its stake in U.S. Physical Therapy by 209.2% in the third quarter. Schroder Investment Management Group now owns 319,373 shares of the company’s stock valued at $20,024,000 after buying an additional 216,073 shares during the period. Citadel Advisors LLC purchased a new stake in U.S. Physical Therapy during the third quarter valued at $530,000. Finally, Allianz Asset Management AG purchased a new stake in U.S. Physical Therapy during the fourth quarter valued at $381,000. Hedge funds and other institutional investors own 96.70% of the company’s stock.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.